$5.01
Insights on Rewalk Robotics Ltd
Revenue is down for the last 2 quarters, 6.88M → 5.28M (in $), with an average decrease of 23.3% per quarter
Netprofit is down for the last 2 quarters, -5.63M → -6.27M (in $), with an average decrease of 11.3% per quarter
1.0%
Downside
Day's Volatility :2.94%
Upside
1.96%
88.8%
Downside
52 Weeks Volatility :92.84%
Upside
36.1%
Period | Rewalk Robotics Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -17.67% | 0.0% |
6 Months | 576.09% | 0.0% |
1 Year | 724.12% | 0.0% |
3 Years | 178.57% | -20.1% |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
Sell
Neutral
Buy
Rewalk Robotics Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Rewalk Robotics Ltd | 3.68% | 576.09% | 724.12% | 178.57% | 68.44% |
Stryker Corporation | 0.86% | 12.4% | 15.49% | 28.53% | 77.74% |
Boston Scientific Corp. | 11.25% | 36.51% | 40.96% | 76.8% | 100.56% |
Edwards Lifesciences Corp. | 3.89% | 34.72% | 1.32% | -5.35% | 56.97% |
Abbott Laboratories | -3.84% | 0.25% | -4.89% | -12.22% | 35.01% |
Medtronic Plc | 5.71% | 8.68% | -4.84% | -33.51% | -4.04% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Rewalk Robotics Ltd | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | NA |
Stryker Corporation | 37.6 | 37.6 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.33 | 63.33 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 38.77 | 38.77 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 32.15 | 32.15 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 26.83 | 26.83 | 1.52 | 5.2 | 0.08 | 0.04 | 0.03 | 38.95 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Rewalk Robotics Ltd | NA | $43.0M | 68.44% | NA | 0.0% |
Stryker Corporation | Buy | $125.6B | 77.74% | 37.6 | 16.03% |
Boston Scientific Corp. | Buy | $110.8B | 100.56% | 63.33 | 12.05% |
Edwards Lifesciences Corp. | Buy | $54.4B | 56.97% | 38.77 | 23.01% |
Abbott Laboratories | Buy | $179.5B | 35.01% | 32.15 | 13.96% |
Medtronic Plc | Buy | $112.2B | -4.04% | 26.83 | 13.0% |
exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the
Organization | Rewalk Robotics Ltd |
Employees | 108 |
CEO | Mr. Lawrence J. Jasinski BS, MBA |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$5.01
-1.18%
Keyarch Acquisition Corp
$5.01
-1.18%
Connexa Sports Technologies Inc
$5.01
-1.18%
Us Value Etf
$5.01
-1.18%
First Wave Biopharma Inc
$5.01
-1.18%
Global X Msci Next Emerging
$5.01
-1.18%
Fat Projects Acquisition Corp
$5.01
-1.18%
Ishares Intl Div Growth Etf
$5.01
-1.18%
Corsair Gaming, Inc.
$5.01
-1.18%